Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.33 | -$0.32 | -$0.33 |
| Q2 2026 | 3 | -$0.29 | -$0.27 | -$0.28 |
| Q3 2026 | 3 | -$0.29 | -$0.28 | -$0.29 |
| Q4 2026 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q1 2027 | 1 | -$0.28 | -$0.27 | -$0.28 |
| Q2 2027 | 1 | -$0.25 | -$0.24 | -$0.25 |
| Q3 2027 | 1 | -$0.25 | -$0.24 | -$0.25 |
| Q4 2027 | 1 | -$0.23 | -$0.22 | -$0.22 |
| Q1 2028 | 1 | $0.15 | $0.15 | $0.15 |
| Q2 2028 | 1 | $0.16 | $0.16 | $0.16 |
| Q3 2028 | 1 | $0.13 | $0.14 | $0.14 |
| Q4 2028 | 1 | $0.26 | $0.27 | $0.27 |
Pulmonx Corp last posted its earnings results on Wednesday, April 29th, 2026. The company reported $-0.33 earnings per share for the quarter, missing analysts' consensus estimates of $-0.33 by $0. The company had revenue of 20.59 M for the quarter and had revenue of 90.50 M for the year. Pulmonx Corp has generated $-1 earnings per share over the last year ($-1.33 diluted earnings per share) and currently has a price-to-earnings ratio of -0.98. Pulmonx Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/04/2026 | Q1 2026 | N/A | -$0.33 | N/A | $20.43 M | $20.59 M |
| 03/10/2026 | Q4 2025 | N/A | -$0.25 | N/A | $21.73 M | $22.60 M |
| 11/12/2025 | Q3 2025 | -$0.40 | -$0.34 | 0.06 | $20.98 M | $21.50 M |
| 08/01/2025 | Q2 2025 | N/A | -$0.38 | N/A | $23.65 M | $23.86 M |
| 05/02/2025 | Q1 2025 | N/A | -$0.36 | N/A | $22.03 M | $22.54 M |
| 02/25/2025 | Q4 2024 | N/A | -$0.33 | N/A | $22.29 M | $23.77 M |
| 11/01/2024 | Q3 2024 | N/A | -$0.36 | N/A | $20.29 M | $20.39 M |
| 08/02/2024 | Q2 2024 | N/A | -$0.39 | N/A | $20.15 M | $20.78 M |
| 05/03/2024 | Q1 2024 | N/A | -$0.36 | N/A | $18.03 M | $18.85 M |
| 02/27/2024 | Q4 2023 | N/A | -$0.36 | N/A | N/A | $19.28 M |
| 11/03/2023 | Q3 2023 | N/A | -$0.39 | N/A | N/A | $17.67 M |
| 08/04/2023 | Q2 2023 | N/A | -$0.43 | N/A | N/A | $17.19 M |
| 05/08/2023 | Q1 2023 | N/A | -$0.42 | N/A | N/A | $14.54 M |
| 03/01/2023 | Q4 2022 | N/A | -$0.38 | N/A | N/A | $15.43 M |
| 11/08/2022 | Q3 2022 | N/A | -$0.37 | N/A | N/A | $13.50 M |
| 08/08/2022 | Q2 2022 | N/A | -$0.40 | N/A | N/A | $13.95 M |
| 05/09/2022 | Q1 2022 | N/A | -$0.43 | N/A | N/A | $10.79 M |
| 03/01/2022 | Q4 2021 | N/A | -$0.35 | N/A | N/A | $13.71 M |
| 11/09/2021 | Q3 2021 | N/A | -$0.28 | N/A | N/A | $13.26 M |
| 08/10/2021 | Q2 2021 | N/A | -$0.34 | N/A | N/A | $12.20 M |
The conference call for Pulmonx Corp's latest earnings report can be listened to online.
The conference call transcript for Pulmonx Corp's latest earnings report can be read online.
Pulmonx Corp (:LUNG) has a recorded annual revenue of $90.50 M.
Pulmonx Corp (:LUNG) has a recorded net income of $-54,003,000.Pulmonx Corp has generated $-1.33 earnings per share over the last four quarters.
Pulmonx Corp (:LUNG) has a price-to-earnings ratio of -0.98 and price/earnings-to-growth ratio is -0.09.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED